Rezultati - Gail J. Roboz

Refine Results
  1. 1
    Novel Approaches to the Treatment of Acute Myeloid Leukemia

    Novel Approaches to the Treatment of Acute Myeloid Leukemia od Gail J. Roboz

    Izdano 2011
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Acute myeloid leukemia stem cells: seek and destroy

    Acute myeloid leukemia stem cells: seek and destroy od Gail J. Roboz, Mónica L. Guzmán

    Izdano 2009
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis

    Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis od Gail J. Roboz, Sérgio Dias, George Lam, William J. Lane, Steven L. Soignet, Raymond P. Warrell, Shahin Rafii

    Izdano 2000
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    The BiTE (bispecific T‐cell engager) platform: Development and future potential of a targeted immuno‐oncology therapy across tumor types

    The BiTE (bispecific T‐cell engager) platform: Development and future potential of a targeted immuno‐oncology therapy across tumor types od Hermann Einsele, Hossein Borghaei, Robert Z. Orlowski, Marion Subklewe, Gail J. Roboz, Gerhard Zugmaier, Peter Kufer, Karim Iskander, Hagop M. Kantarjian

    Izdano 2020
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Prevalence, Management, and Clinical Consequences of QT Interval Prolongation During Treatment With Arsenic Trioxide

    Prevalence, Management, and Clinical Consequences of QT Interval Prolongation During Treatment With Arsenic Trioxide od Gail J. Roboz, Ellen K. Ritchie, Rebecca F. Carlin, Michael S. Samuel, Leanne Gale, Juliette L. Provenzano-Gober, Tania J. Curcio, Eric J. Feldman, Paul Kligfield

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia

    Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia od Ellen K. Ritchie, Eric J. Feldman, Paul J. Christos, Sarah D. Rohan, Catherine B. Lagassa, Cindy Ippoliti, Joseph M. Scandura, Karen-Sue Carlson, Gail J. Roboz

    Izdano 2012
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    The effect of initial molecular profile on response to recombinant interferon‐α (rIFNα) treatment in early myelofibrosis

    The effect of initial molecular profile on response to recombinant interferon‐α (rIFNα) treatment in early myelofibrosis od Richard T. Silver, Ariella Barel, Elena Lascu, Ellen K. Ritchie, Gail J. Roboz, Paul J. Christos, Attilio Orazi, Duane C. Hassane, Wayne Tam, Nicholas C.P. Cross

    Izdano 2017
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    TP53 Mutations Predict Poorer Responses to CPX-351 in Acute Myeloid Leukemia

    TP53 Mutations Predict Poorer Responses to CPX-351 in Acute Myeloid Leukemia od Aaron D. Goldberg, Chetasi Talati, Pinkal Desai, Christopher Famulare, Sean M. Devlin, Noushin Farnoud, David A. Sallman, Jeffrey E. Lancet, Gail J. Roboz, Kendra Sweet, Martin S. Tallman

    Izdano 2018
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response

    A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response od Keith W. Pratz, Jorge E. Cortés, Gail J. Roboz, Niranjan Rao, Omotayo Arowojolu, Adam Stine, Yukimasa Shiotsu, Aiko Shudo, Shiro Akinaga, Donald Small, Judith E. Karp, Mark J. Levis

    Izdano 2008
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche

    In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche od Hong Zong, Siddhartha Sen, Guodong Zhang, Mu Chuanjie, Z F Albayati, David G. Gorenstein, Yang Liu, M. Ferrari, Peter A. Crooks, Gail J. Roboz, Haifa Shen, Mónica L. Guzmán

    Izdano 2015
    Polni tekst
    Carta
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels

    FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels od Vicenta Trujillo-Alonso, Edwin C. Pratt, Hongliang Zong, Andres Lara-Martinez, Charalambos Kaittanis, Mohamed O. Rabie, Valerie A. Longo, Michael W. Becker, Gail J. Roboz, Jan Grimm, Mónica L. Guzmán

    Izdano 2019
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    A Chemical Biology Approach to the Chaperome in Cancer—HSP90 and Beyond

    A Chemical Biology Approach to the Chaperome in Cancer—HSP90 and Beyond od Tony Taldone, Tai Wang, Anna Rodina, Nagavarakishore Pillarsetty, Chander Singh Digwal, Sahil Sharma, Pengrong Yan, Suhasini Joshi, Piyusha P. Pagare, Alexander Bolaender, Gail J. Roboz, Mónica L. Guzmán, Gabriela Chiosis

    Izdano 2019
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations

    Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations od Nuria Mencia-Trinchant, Yang Hu, Maria Antonina Alas, Fatima Bhopalwala Ali, Bas J. Wouters, Sang Min Lee, Ellen K. Ritchie, Pinkal Desai, Mónica L. Guzmán, Gail J. Roboz, Duane C. Hassane

    Izdano 2017
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Somatic mutations precede acute myeloid leukemia years before diagnosis

    Somatic mutations precede acute myeloid leukemia years before diagnosis od Pinkal Desai, Nuria Mencia-Trinchant, Oleksandr Savenkov, Michael S. Simon, Gloria Cheang, Sang‐Min Lee, Michael Samuel, Ellen K. Ritchie, Mónica L. Guzmán, Karla V. Ballman, Gail J. Roboz, Duane C. Hassane

    Izdano 2018
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

    First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leuk... od Eric J. Feldman, Jeffrey E. Lancet, Jonathan E. Kolitz, Ellen K. Ritchie, Gail J. Roboz, Alan F. List, Steven L. Allen, Ekatherine Asatiani, Lawrence D. Mayer, Christine E. Swenson, Arthur C. Louie

    Izdano 2011
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (m <i>IDH1</i> ) acute myeloid leukemia (AML)

    Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (m <i>IDH1</i> ) acute myeloid leukemia (AML) od Jorge E. Cortés, Brian A. Jonas, Gary J. Schiller, Alice S. Mims, Gail J. Roboz, Andrew H. Wei, Pau Montesinos, P. Brent Ferrell, Karen Yee, Pierre Fenaux, Anthony P. Schwarer, Justin M. Watts

    Izdano 2024
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML

    Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML od Joseph M. Scandura, Gail J. Roboz, Michelle Moh, Ewelina Morawa, Fabienne Brenet, Jahar R Bose, Luis Juárez Villegas, Usama Gergis, Sebastian Mayer, Cindy Ippoliti, Tania J. Curcio, Ellen K. Ritchie, Eric J. Feldman

    Izdano 2011
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia

    Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia od Gail J. Roboz, Ellen K. Ritchie, Yulia Dault, Linda Lam, Danielle C. Marshall, Nicole M. Cruz, Hsiao-Ting Hsu, Duane C. Hassane, Paul J. Christos, Cindy Ippoliti, Joseph M. Scandura, Mónica L. Guzmán

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    Selective Activity of the Histone Deacetylase Inhibitor AR-42 against Leukemia Stem Cells: A Novel Potential Strategy in Acute Myelogenous Leukemia

    Selective Activity of the Histone Deacetylase Inhibitor AR-42 against Leukemia Stem Cells: A Novel Potential Strategy in Acute Myelogenous Leukemia od Mónica L. Guzmán, Neng Yang, Krishan K. Sharma, Marlene Balys, Cheryl A. Corbett, Craig T. Jordan, Michael W. Becker, Ulrich Steidl, Omar Abdel‐Wahab, Ross L. Levine, Guido Marcucci, Gail J. Roboz, Duane C. Hassane

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia

    Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia od Mayumi Sugita, Román Galetto, Hongliang Zong, Nathan Ewing-Crystal, Vicenta Trujillo-Alonso, Nuria Mencia-Trinchant, Winnie Yip, Stéphanie Filipe, Céline Lebuhotel, Agnès Gouble, Duane C. Hassane, Julianne Smith, Gail J. Roboz, Mónica L. Guzmán

    Izdano 2022
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: